搜尋結果
US FDA approves Neurocrine Biosciences' movement disorder drug
Reuters· 1 日前, opens new tab Ingrezza drug to treat movement disorders associated with Huntington's disease (HD), the company said on ...
World's largest olive oil producer says the industry faces one of its toughest moments ever
CNBC· 1 日前Extreme hot weather and persistent drought conditions have dealt a severe blow to olive oil ...
UN right chief troubled by treatment of pro-Palestinian protesters at U.S. universities
Reuters· 3 日前"I am concerned that some of law enforcement actions across a series of universities ...
BOC HONG KONG Keeps HKD Prime Rate at 5.875%
AASTOCKS.com· 1 日前AASTOCKS.com Limited, HKEx Information Services Limited, China Investment Information Services ...
Heritage Museum's exhibition "Timeless Diva: Anita Mui" receives its 200 000th visitor
Bastillepost· 1 日前The Monetary Authority announced today (May 3) that the countercyclical capital buffer (CCyB) ...
Kara Swisher On Pessimistic Optimism And Burn Book: A Tech Love Story
Forbes· 4 日前Kara Swisher is one of the most influential thinkers and commentators in the world of ...
US bill aims to rename street of Hong Kong trade office ‘Jimmy Lai Way,’ as city condemns ...
Hong Kong Free Press· 3 日前According to a press release from Republican congressman Chris Smith last Thursday, the Hong ...
S.Korea pension fund targets ratio of risky assets at 65% in new portfolio
Reuters· 1 日前South Korea's National Pension Service (NPS), manager of the world's third-largest public pension fund, will allocate 65% ...
Taylor Swift fans buy out Times Square billboard ad for Hot 100 achievement
Marketing Magazine· 1 日前Fans of Taylor Swift (or Swifties) bought an ad space on a billboard at New York's Times ...
Swedish Bankruptcies in 21-Month Surge Show No Signs of Easing
Bloomberg· 1 日前Bankruptcies in Sweden extended their streak of annual increases to 21 months in April, ...